Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept : 2-year outcomes.

Bathon, J;Robles, M;Ximenes, A C;Nayiager, S;Westhovens, R;et.al.
(2011) Annals of the Rheumatic Diseases — Vol. 70, n° 11, p. 1949-1956 (2011)

Files

No attached file found for this publication.

Details

Authors
  • Bathon, J
    Author
  • Robles, M
    Author
  • Ximenes, A C
    Author
  • Nayiager, S
    Author
  • Durez, PatrickUCLouvain
    Author
  • Westhovens, R
    Author
Show more
Abstract
To assess the efficacy and safety of abatacept plus methotrexate versus methotrexate alone in early erosive rheumatoid arthritis (RA).
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Bathon, J., Robles, M., Ximenes, A. C., Nayiager, S., Wollenhaupt, J., Durez, P., Gomez-Reino, J., Grassi, W., Haraoui, B., Shergy, W., Park, S.-H., Genant, H., Peterfy, C., Becker, J.-C., Covucci, A., Moniz Reed, D., Helfrick, R., & Westhovens, R. (2011). Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept : 2-year outcomes. Annals of the Rheumatic Diseases, 70(11), 1949-1956. https://doi.org/10.1136/ard.2010.145268 (Original work published 2011)